Response to induction, early mobilisation and pre-autologous transplant use of bortezomib and/or thalidomide prolong progression free and/or overall survival in myeloma

BEKSAÇ M., UĞUR BİLGİN A., SOYDAN E., ÖZKOCAMAN V., TOPÇUOĞLU P., EVRANOS B., ...Daha Fazla

34th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/24nd Meeting of the EBMT-Nurses-Group/7th Meeting of the EBMT-Data-Management-Group, 30 Mart - 02 Nisan 2008, (Özet Bildiri)

• Yayın Türü: Bildiri / Özet Bildiri
• Bursa Uludağ Üniversitesi Adresli: Evet